[1] Tan C, Qiao M, Ma Y, et al., 2023, The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Affective Disorders, 337: 37–49.

[2] Huang Y, Wang Y, Wang H, et al., 2019, Prevalence of Mental Disorders in China: A Cross-sectional Epidemiological Study. The Lancet Psychiatry, 6(3): 211–224.

[3] Shen WY, Zeng YX, Li WH, et al., 2021, Analysis of the Current Status and Trends of Depression Burden in China Based on GBD Big Data. Occupational and Health, 37(8): 1087–1092.

[4] Tian W, Yan G, Xiong S, et al., 2026, Burden of Depressive and Anxiety Disorders in China and Its Provinces, 1990–2021: Findings from the Global Burden of Disease Study 2021. The British Journal of Psychiatry, 228(1): 18–28.

[5] McIntyre RS, Alsuwaidan M, Baune BT, et al., 2023, Treatment-resistant Depression: Definition, Prevalence, Detection, Management, and Investigational Interventions. World Psychiatry, 22(3): 394–412.

[6] Nierenberg AA, Husain MM, Trivedi MH, et al., 2010, Residual Symptoms After Remission of Major Depressive Disorder With Citalopram and Risk of Relapse: A STAR*D Report. Psychological Medicine, 40(1): 41–50.

[7] Yao Y, Yang CY, Xu YQ, et al., 2020, Controlled Observation of Cognitive Behavioral Therapy on Cognitive Function Improvement in Elderly Patients With Depression. International Journal of Psychiatry, 47(1): 67–70.

[8] Chang N, Zhao LL, Hu J, et al., 2021, Effects of Paroxetine Combined With Cognitive Behavioral Therapy on Behavioral Management and Self-efficacy in Patients With Coronary Heart Disease and Depression. Practical Drugs and Clinical Medicine, 24(10): 929–932.

[9] Meng QS, Liu Q, Xin KP, 2025, The Effect of Cognitive Behavioral Therapy Combined With Psychological Support on the Quality of Life in Elderly Patients With Depression. Psychological Monthly, 20(13): 162–164.

[10] V RJ, Mathias EG, Bhavana RS, et al., 2025, Barriers and Facilitators of Implementing Cognitive Behavioral Therapy: A Systematic Review Based on the Consolidated Framework for Implementation. Scientifica, 2693791.

[11] Bickman L, 2020, Improving Mental Health Services: A 50-year Journey From Randomized Experiments to Artificial Intelligence and Precision Mental Health. Administration and Policy in Mental Health, 47(5): 795–843.

[12] Kim T, Bae S, Kim HA, et al., 2024, Mindful Diary: Harnessing Large Language Models to Support Psychiatric Patients’ Journaling. In CHI 2024 – Proceedings of the 2024 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery, the Republic of Korea.

[13] Habicht J, Dina LM, McFadyen J, et al., 2025, Generative AI-enabled Therapy Support Tool for Improved Clinical Outcomes and Patient Engagement in Group Therapy: A Real-world Observational Study. Journal of Medical Internet Research, 27: e60435.

[14] Trapp NT, Purgianto A, Taylor JJ, et al., 2025, Consensus Review and Considerations on TMS to Treat Depression: A Comprehensive Update Endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology. Clinical Neurophysiology, 170: 206–233.

[15] Vida RG, Saghy E, Bella R, et al., 2023, Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Adjunctive Therapy for Major Depressive Disorder (MDD) After Two Antidepressant Treatment Failures: Meta-analysis of Randomized Sham-controlled Trials. BMC Psychiatry, 23: 545.

[16] Ventureyra EC, 2000, Transcutaneous Vagus Nerve Stimulation for Partial Onset Seizure Therapy. A New Concept. Child’s Nervous System, 16(2): 101–102.

[17] Chen Y, Zhang Y, Wang J, et al., 2023, Anti-neuroinflammatory Effects of Transcutaneous Auricular Vagus Nerve Stimulation Against Depression-like Behaviors via Hypothalamic α7nAchR/JAK2/STAT3/NF-κB Pathway in Rats Exposed to Chronic Unpredictable Mild Stress. CNS Neuroscience & Therapeutics, 29(9): 2634–2644.

[18] Rong P, Liu J, Wang L, et al., 2016, Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Major Depressive Disorder: A Non-randomized Controlled Pilot Study. Journal of Affective Disorders, 195: 172–179.

[19] Conway CR, Sheline YI, Chibnall JT, et al., 2012, Changes in Cerebral Blood Flow With Acute Vagus Nerve Stimulation in Treatment-refractory Major Depressive Disorder. Brain Stimulation, 5(2): 163–171.

[20] Conway CR, Sheline YI, Chibnall JT, et al., 2006, Changes in Cerebral Blood Flow During Vagus Nerve Stimulation for Depression. Psychiatry Research, 146(2): 179–184.

[21] Lomarev M, Denslow S, Nahas Z, et al., 2002, Vagus Nerve Stimulation (VNS) Synchronized BOLD fMRI Suggests That VNS in Depressed Adults Has Frequency/dose-dependent Effects. Journal of Psychiatric Research, 36(4): 219–227.

[22] Mu Q, Bohning DE, Nahas Z, et al., 2004, Acute Vagus Nerve Stimulation Using Different Pulse Widths Produces Varying Brain Effects. Biological Psychiatry, 55(8): 816–825.

[23] He W, Jing XH, Zhu B, et al., 2013, The Auriculo-vagal Afferent Pathway and Its Role in Seizure Suppression in Rats. BMC Neuroscience, 14: 85.

[24] Conway CR, Chibnall JT, Gebara MA, et al., 2013, Association of Cerebral Metabolic Activity Changes With Vagus Nerve Stimulation Antidepressant Response in Treatment-resistant Depression. Brain Stimulation, 6(5): 788–797.

[25] Landau AM, Dyve S, Jakobsen S, et al., 2015, Acute Vagal Nerve Stimulation Reduces α2 Adrenoceptor Availability: Possible Mechanism of Therapeutic Action. Brain Stimulation, 8(4): 702–707.

[26] Dietrich S, Smith J, Scherzinger C, et al., 2008, A Novel Transcutaneous Vagus Nerve Stimulation Leads to Brainstem and Cerebral Activations Measured by Functional MRI. Biomedizinische Technik, 53(3): 104–111.

[27] Kraus T, Hosl K, Kiess O, et al., 2007, BOLD fMRI Deactivation of Limbic and Temporal Brain Structures and Mood-enhancing Effect by Transcutaneous Vagus Nerve Stimulation. Journal of Neural Transmission, 114(11): 1485–1493.

[28] Kraus T, Kiess O, Hosl K, et al., 2013, CNS BOLD fMRI Effects of Sham-controlled Transcutaneous Electrical Nerve Stimulation in the Left Outer Auditory Canal-a Pilot Study. Brain Stimulation, 6(5): 798–804.

[29] Hein E, Nowak M, Kiess O, et al., 2013, Auricular Transcutaneous Electrical Nerve Stimulation in Depressed Patients: A Randomized Controlled Pilot Study. Journal of Neural Transmission, 120(5): 821–827.

[30] Rong P, Liu J, Wang L, et al., 2016, Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Major Depressive Disorder: A Non-randomized Controlled Pilot Study. Journal of Affective Disorders, 195: 172–179.

[31] Tan C, Qiao M, Ma Y, et al., 2023, Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Affective Disorders, 337: 37–49.

[32] Evensen K, Jørgensen MB, Sabers A, et al., 2022, Transcutaneous Vagal Nerve Stimulation in Treatment-resistant Depression: A Feasibility Study. Neuromodulation, 25(3): 443–449.

[33] Xiao X, Hou X, Zhang Z, et al., 2020, Efficacy and Brain Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation for Adolescents With Mild to Moderate Depression: Study Protocol for a Randomized Controlled Trial. Pediatric Investigation, 4(2): 109–117.

[34] Austelle CW, Cox SS, Connolly DJ, et al., 2025, Accelerated Transcutaneous Auricular Vagus Nerve Stimulation for Inpatient Depression and Anxiety: The iWAVE Open-label Pilot Trial. Neuromodulation, 28(4): 672–681.

[35] Kim AY, Marduy A, de Melo PS, et al., 2022, Safety of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS): A Systematic Review and Meta-analysis. Scientific Reports, 12(1): 22055.